Finepoint Capital LP has filed its 13F form on November 13, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.31 Billion distributed in 9 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Rxo, Inc. with a value of $112M, Solid Biosciences Inc with a value of $0, Qxo Inc with a value of $0, Money Hero LTD with a value of $0, and Calidi Biotherapeutics Inc with a value of $0.

Examining the 13F form we can see an increase of $456M in the current position value, from $851M to 1.31B.

Finepoint Capital LP is based out at Boston, MA

Below you can find more details about Finepoint Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $1.31 Billion
ETFs: $1.2 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 9
  • Current Value $1.31 Billion
  • Prior Value $851 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 13, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 2 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Finepoint Capital LP Portfolio

Follow Finepoint Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Finepoint Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Finepoint Capital LP with notifications on news.